Back to Grants
FEDERAL
Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)
This grant funds research aimed at developing new therapeutic strategies for previously undruggable targets in disease treatment.
About this program
The grant focuses on innovative approaches to drug discovery, specifically targeting proteins and pathways that have been historically difficult to modulate with small molecules. It is intended for researchers in the biomedical field who are exploring novel methodologies to expand the druggable genome. The program encourages interdisciplinary collaboration and aims to foster the development of groundbreaking therapies that can address unmet medical needs.
Eligibility
Eligible applicants include academic institutions, nonprofit organizations, and small businesses engaged in biomedical research.
Requirements
- Research proposal must focus on undruggable targets
- Collaboration with industry partners is encouraged